Thyrotropin alfa

Thyrotropin alfa (also known as thyroid stimulating hormone, TSH, or thyrotropin) is a biopharmaceutical medication that is used to diagnose thyroid disorders and to monitor the treatment of thyroid cancer. It is a recombinant form of the human thyroid-stimulating hormone.

Medical uses

Thyrotropin alfa is used in the diagnosis of hypothyroidism, hyperthyroidism, and certain types of thyroid cancer. It is also used to monitor the treatment of thyroid cancer.

Mechanism of action

Thyrotropin alfa works by stimulating the thyroid gland to produce more thyroid hormone. This helps to regulate the body's metabolism and energy levels.

Side effects

Common side effects of thyrotropin alfa include nausea, headache, fatigue, and dizziness. In rare cases, it can cause serious side effects such as allergic reactions, heart problems, and stroke.

History

Thyrotropin alfa was first approved for medical use in the United States in 1998. It is marketed under the brand name Thyrogen by Genzyme.

See also

• List of medications
• Thyroid disease
• Thyroid function tests

Thyrotropin alfa Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski

References

External links

• FDA Approval History
• Official Website

Further reading

• "Thyrotropin alfa for the detection of thyroid remnant or cancer"
• "Thyrotropin alfa in the management of patients with thyroid cancer"